Company Description
When it comes to developing new and better biotech drugs, Biogen Idec believes two heads are better than one. The biotech giant, formed from the...
Key Biogen Idec Financials
| Company Type | Public - NASDAQ (GS): BIIB Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $3,171.6 |
| 2007 Employees | 4,300 |
More Biogen Idec Financials (11 pages)
Latest Biogen Idec Jobs powered by Monster.com
- Associate Scientist II, Molecular Discovery
- CMC Leader, Small Molecules CMC Programs
- CMC Leader, Small Molecules CMC Programs
Rankings
- S&P 500
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Biogen Idec's competition across multiple industries
Top Biogen Idec Competitors
Sponsored Links
The Business Directory
Biogen Idec Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Bruce R. Ross | Network | E-mail |
| President, CEO and Director | James C. (Jim) Mullen | Network | E-mail |
| EVP New Ventures | John M. Dunn | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Biogen Idec News
- Biogen Idec Incorporated(GAAP) (BIIB.GP) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 02:27:00 EDT)
- Biogen Idec Incorporat(Alt EPS) (BIIB.AL) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 01:16:00 EDT)
-
Biogen Idec Incorporated (NASD:BIIB) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 00:26:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.